CD8A and glioblastoma: In the GL261 syngeneic mouse GBM model, irradiated GL261 pulsed with α-GalCer and doxicyclin induced CD8+ T cell-mediated anti-tumor response in both prophylactic and therapeutic settings (6 days after tumor implantation) [100].